Rashdesk

Small-town chemists send standard skin photos to a dermatologist within hours

SMEs Tier 2–3 Cities

TL;DR Rashdesk puts a store-and-forward dermatology service at the chemist counter in small towns. The pharmacist takes a fixed set of photos, a registered dermatologist replies within hours, and the patient pays a small fee. It works because rashes, fungal infections and acne are common and dermatologists are not.

The problem

India has roughly one dermatologist for every 130,000 people, based on about 12,740 IADVL members[1], and they cluster in cities. In a small town, the first stop for an itchy rash is usually the chemist, who is not allowed to diagnose and often sells whatever cream the customer asks for.

The cost shows up later - fungal infections that keep coming back, acne scars and conditions that needed a doctor weeks earlier.

App-based options exist, but they ask the patient to download an app, take decent photos alone and book a slot. Will someone in a tier-3 town do all of that for a rash? Mostly not.

The idea

What it does, in regulatory terms - teleconsultation by a registered dermatologist under the Telemedicine Practice Guidelines 2020. The software only checks photo quality and completeness, and it does not suggest a diagnosis.[2] That keeps it clear of CDSCO's medical device software rules[3].

The chemist uses a phone with a clip-on lens to capture a fixed set - close-up, wide shot and body map, plus a short history form. The app rejects blurry or incomplete cases before a doctor sees them. A dermatologist on the panel replies within four hours with advice and, where allowed, a prescription the patient can fill anywhere. Cases needing a physical exam are referred to a named clinic.

The seed proposed AI that assesses skin directly, and I've reframed it. A 2026 meta-analysis of 155 studies found teledermatology agreed with in-person diagnosis 76% of the time[4], and that is with doctors reading the photos. An unproven algorithm on Indian skin tones adds risk without a clear gain.

Who pays

The patient pays per case. Clinikally charges ₹269 for a 20-minute video consult with a free follow-up[5], which sets the price ceiling. A ₹149–249 counter fee, shared with the chemist, is my assumption. The chemist gains a reason for repeat visits and sells the prescribed medicine. Dermatologists on the panel are paid per case, which suits young specialists building a practice.

Why now

CDSCO finalised its guidance on medical device software in July 2026[3], so the line between workflow software and a regulated diagnostic tool is now written down. One large skin-care app says it has helped over 17 lakh Indians with photo-based dermatology care[6], which shows people will accept remote skin care.

Market signal

No public figure exists for teledermatology in small-town India. The supply gap is the firmest number you have, at about one dermatologist per 130,000 people[1]. Next to that, that app's 17 lakh users and 83.8K reviews show demand among app users in larger towns[6]. Neither tells you about the chemist counter.

Who's already doing this

The big skin-care apps pair AI photo analysis with a personal dermatologist and their own product range[6]. Online dermatology stores sell video consults and products[5]. Both rely on the patient using an app alone. eSanjeevani offers free government teleconsultation, but not with a specialist at the chemist counter. The gap is an assisted, counter-based route for people who will not self-serve.

How hard is it?

Difficulty Moderate (38/100)
Starting capital ₹40–80 L
Time to launch 4–6 months

The build is light. The hard part is signing chemists who will spend five minutes per case, keeping photo quality high enough for doctors to decide and running a dermatologist panel that answers on time at ₹100-odd per case. Steroid-cream sales at the same counter will test your rules.

Licences and approvals

Yes. Rashdesk is a medical consultation service, so the doctor's rules apply even though the chemist only takes photos.

  • Telemedicine Practice Guidelines 2020, issued by MoHFW. Only a registered dermatologist advises or prescribes, and first teleconsults have drug limits. Follow them from the first case[2].
  • Medical device software scope under CDSCO's 2026 guidance. Photo-quality checks are workflow, but a diagnosis suggestion would bring you in scope, so decide before launch[3].
  • DPDP Act and Rules 2025. Skin photos can be intimate. Take explicit consent per case and stop chemists keeping copies[7].
  • Pharmacy drug licence and pharmacist registration stay with each partner chemist. Check both before you sign them up.

Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.

How AI can power this business

  • Photo quality gate. A model can reject blurry, badly lit or incomplete photo sets at the counter, so the dermatologist only opens cases worth reading.
  • Case routing. Software can send each case to the panel doctor with the shortest queue and chase anyone close to the four-hour limit.
  • Patient instructions in local languages. The dermatologist's advice can be turned into a simple Hindi or regional-language note the chemist prints, after the doctor approves it.
  • Chemist nudges. Data on cases sent per counter can show which chemists are drifting back to selling creams, so your field team visits them first.

Don't let AI suggest a diagnosis or a cream. That's the dermatologist's job, and a diagnostic feature would turn the app into a regulated medical device.

Want to work out the AI layer for Rashdesk? Talk to Yash →

Biggest risks

Here's what can go south -

  • Chemist incentives. Selling a cream takes less time than sending a case, and many will drift back.
  • Photo quality. Remote reading is less accurate than an exam, and worse without good images[4].
  • Thin margins. A low fee split three ways leaves little room for errors or refunds.

Our take

I think it's a reasonable bet for a founder who knows pharmacy distribution in tier-2 and tier-3 towns. If what you really want is to build skin AI then this isn't your idea. Prove one thing first - that 30 chemists in one district will each send at least ten paid cases a month.

Questions founders ask

Plan for roughly ₹40–80 L, mostly chemist onboarding, clip-on lenses, the app and paying a dermatologist panel before volumes build.

Do I need a licence to start a teledermatology business in India?

There's no separate licence for the service, but the doctors must follow the Telemedicine Practice Guidelines, the app must stay outside device scope and you must comply with the DPDP Act.

Can I start a pharmacy-based skin consultation service in another country?

Yes, wherever specialists are scarce outside cities. Check your local telemedicine rules and what pharmacists may do at the counter.

Download the kit

The free Rashdesk validation kit has the line-by-line capital breakdown, the effort scoring, the rules and permissions checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for chemists and patients, and 5 assumptions to test. Download the kit →

Talk to Yash

Thinking about building Rashdesk or something close to it? The make-or-break work is getting chemists to send cases instead of selling creams. If you need a hand, you know where to find me. Talk to Yash →

Sources

  1. Ashique & Kaliyadan, "Teledermatology in the wake of COVID-19 scenario: an Indian perspective", Indian Dermatology Online Journal 11(3), 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7367559/
  2. MoHFW, "Telemedicine Practice Guidelines", 2020-03-25. https://esanjeevani.mohfw.gov.in/assets/guidelines/Telemedicine_Practice_Guidelines.pdf
  3. CDSCO, "Guidance Document on Medical Device Software", 2026-07-21. https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/Guidance-document-on-Medical-Device-Software-under-MDR-2017.pdf
  4. Frontiers in Medicine, "Diagnostic accuracy of teledermatology for skin diseases: a systematic review and meta-analysis", 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12989395/
  5. Clinikally, "Online dermatologist consultation", accessed 2026-10-21. https://www.clinikally.com/pages/consult
  6. CureSkin, official site, accessed 2026-10-21. https://www.cureskin.com/
  7. PIB, "Backgrounder: DPDP Rules, 2025 notified", 2025-11-17. https://static.pib.gov.in/WriteReadData/specificdocs/documents/2025/nov/doc20251117695301.pdf

For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.

Reviews

No reviews yet